HomeCompareTCBP vs PLD

TCBP vs PLD: Dividend Comparison 2026

TCBP yields 400.00% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCBP wins by $11431.32M in total portfolio value
10 years
TCBP
TCBP
● Live price
400.00%
Share price
$0.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11437.82M
Annual income
$7,667,192,697.76
Full TCBP calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — TCBP vs PLD

📍 TCBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCBPPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCBP + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCBP pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCBP
Annual income on $10K today (after 15% tax)
$34,000.00/yr
After 10yr DRIP, annual income (after tax)
$6,517,113,793.10/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, TCBP beats the other by $6,512,645,822.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCBP + PLD for your $10,000?

TCBP: 50%PLD: 50%
100% PLD50/50100% TCBP
Portfolio after 10yr
$5722.16M
Annual income
$3,836,224,566.97/yr
Blended yield
67.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

TCBP
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-14.7
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCBP buys
0
PLD buys
0
No recent congressional trades found for TCBP or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCBPPLD
Forward yield400.00%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$11437.82M$6.50M
Annual income after 10y$7,667,192,697.76$5,256,436.18
Total dividends collected$11090.87M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: TCBP vs PLD ($10,000, DRIP)

YearTCBP PortfolioTCBP Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$50,700$40,000.00$11,255$555.24+$39.4KTCBP
2$243,782$189,532.71$13,062$1,018.59+$230.7KTCBP
3$1,112,560$851,713.55$15,903$1,926.67+$1.10MTCBP
4$4,823,161$3,632,721.39$20,839$3,823.32+$4.80MTCBP
5$19,879,046$14,718,264.42$30,464$8,166.08+$19.85MTCBP
6$77,964,520$56,693,940.88$52,054$19,457.30+$77.91MTCBP
7$291,226,244$207,804,207.46$109,886$54,188.93+$291.12MTCBP
8$1,037,056,355$725,444,273.70$304,030$186,451.18+$1036.75MTCBP
9$3,523,955,262$2,414,304,962.28$1,166,125$840,813.32+$3522.79MTCBP
10$11,437,824,828$7,667,192,697.76$6,504,190$5,256,436.18+$11431.32MTCBP

TCBP vs PLD: Complete Analysis 2026

TCBPStock

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Full TCBP Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this TCBP vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCBP vs SCHDTCBP vs JEPITCBP vs OTCBP vs KOTCBP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.